Androgenetic Alopecia

May 2002 in “ PubMed ”

C Jamin

New to Vascular Endothelial Growth Factor? There is a guide in the encyclopedia. Read the guide →

androgenetic alopecia 5 alpha reductase dihydrotestosterone dermal papilla vascular endothelial growth factor androgen receptor polymorphism insulin-resistant process polycystic ovary auto-immune origin oestrogens 5 alpha reductase inhibitors AGA DHT VEGF androgen receptor insulin resistance PCOS estrogens

Studysummary This review discusses the androgen-dependent and genetic factors of androgenetic alopecia, highlighting differences in its manifestation between men and women, and reports no new clinical results.

Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer ·

View this study on pubmed.ncbi.nlm.nih.gov →

Discuss this study in the Community →

Related Research

8 / 8 results

Androgen Receptor-Mediated Paracrine Signaling Induces Regression of Blood Vessels in the Dermal Papilla in Androgenetic Alopecia

research Androgen Receptor-Mediated Paracrine Signaling Induces Regression of Blood Vessels in the Dermal Papilla in Androgenetic Alopecia

6 citations , January 2022 in “Journal of Investigative Dermatology”

This study found that androgen receptor signaling is linked to blood vessel regression in the dermal papilla of balding scalp, contributing to hair follicle miniaturization in androgenetic alopecia.

research Gender Differences in Production and Circulating Levels of Sex Hormones and Their Impact on Aging Skin

September 2014 in “Springer eBooks”

This review discusses how sex hormone levels and local steroid synthesis influence gender differences in aging skin, reporting no new clinical results.

research Minoxidil to Treat Androgenetic Alopecia in Men and Women: What Is It and How Does It Work?

January 2014 in “American Journal of Medicine and Medical Sciences”

This article discusses the mechanisms of androgenetic alopecia and explores possible explanations for minoxidil's effect on hair growth but reports no new results.

research A Mouse Model of Androgenetic Alopecia

42 citations , March 2010 in “Endocrinology”

This study reports the development of the first rodent model for androgenetic alopecia, demonstrating that overexpression of androgen receptors in mice delays hair regeneration and can be used to test new treatments.

research Male Androgenetic Alopecia

17 citations , December 2004 in “The Journal of Men's Health & Gender”

This article discusses the role of androgens in hair follicle changes, explaining how dihydrotestosterone contributes to hair thinning on the scalp, while promoting thicker facial hair in men, and reports no new clinical results.

research Androgenetic Alopecia: Pathogenesis and Potential for Therapy

174 citations , November 2002 in “Expert Reviews in Molecular Medicine”

This review discusses the genetic factors contributing to androgenetic alopecia and highlights the potential for developing more effective therapies based on recent discoveries, but reports no new clinical results.

research Molecular Mechanisms of Androgenetic Alopecia

229 citations , August 2002 in “Experimental Gerontology”

This paper discusses key mechanisms of androgen metabolism in androgenetic alopecia and reports the effectiveness of treatments like oral finasteride and topical minoxidil, highlighting the limited success rate due to factors like follicular inflammation.

research Clinical Updates in Hair

19 citations , January 1997 in “Dermatologic Clinics”

This chapter reviews various antiandrogens and androgen inhibitors, detailing their mechanisms, uses, and side effects, with a focus on spironolactone, finasteride, dutasteride, and oral contraceptives.